---
title: "TLDR_brignole2018ESCGuidelines2018"
date: "2024-06-16"
enableToc: false
tags:
    - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ªï¼š[[test]]

# TLDR_brignole2018ESCGuidelines2018

[Kim. 2019. *1529P - Phase II study of osimertinib in NSCLC patients with EGFR exon 20 insertion mutation: A multicenter trial of the Korean Cancer Study Group (LU17-19)*](zotero://select/items/1_PBL9WIC5)

[[TLDR_kim_1529p_2019]]
